UBS Group AG trimmed its holdings in Gevo, Inc. (NASDAQ:GEVO – Free Report) by 36.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,055,352 shares of the energy company’s stock after selling 3,470,155 shares during the period. UBS Group AG owned 2.50% of Gevo worth $12,111,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Rafferty Asset Management LLC acquired a new stake in Gevo in the 3rd quarter valued at about $561,000. Mackenzie Financial Corp acquired a new stake in Gevo in the 3rd quarter valued at about $29,000. Legal & General Group Plc acquired a new stake in Gevo in the 2nd quarter valued at about $28,000. BNP Paribas Financial Markets lifted its holdings in Gevo by 138.1% in the 2nd quarter. BNP Paribas Financial Markets now owns 20,927 shares of the energy company’s stock valued at $28,000 after purchasing an additional 12,136 shares in the last quarter. Finally, Key Client Fiduciary Advisors LLC acquired a new stake in shares of Gevo during the 4th quarter worth about $25,000. 35.17% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider Lindsay Clinton Fitzgerald sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $2.51, for a total value of $50,200.00. Following the sale, the insider directly owned 212,199 shares of the company’s stock, valued at approximately $532,619.49. This trade represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary W. Mize sold 107,100 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $2.33, for a total transaction of $249,543.00. Following the completion of the sale, the director directly owned 281,226 shares in the company, valued at $655,256.58. This represents a 27.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 273,547 shares of company stock valued at $702,348. Insiders own 7.09% of the company’s stock.
Gevo Price Performance
Gevo (NASDAQ:GEVO – Get Free Report) last released its earnings results on Thursday, May 7th. The energy company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.03). Gevo had a negative return on equity of 5.06% and a negative net margin of 19.38%.The company had revenue of $42.95 million during the quarter, compared to analyst estimates of $44.90 million. As a group, sell-side analysts expect that Gevo, Inc. will post -0.1 EPS for the current year.
Analysts Set New Price Targets
Several research firms have issued reports on GEVO. Zacks Research cut shares of Gevo from a “hold” rating to a “strong sell” rating in a research note on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Gevo in a research note on Tuesday, April 21st. Wall Street Zen cut shares of Gevo from a “hold” rating to a “strong sell” rating in a research note on Sunday, May 10th. Finally, Northland Securities set a $3.50 price target on shares of Gevo and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Gevo presently has a consensus rating of “Hold” and a consensus target price of $6.58.
View Our Latest Stock Analysis on GEVO
Gevo Company Profile
Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company’s core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo’s integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.
Gevo’s primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.
Featured Stories
- Five stocks we like better than Gevo
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding GEVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Gevo, Inc. (NASDAQ:GEVO – Free Report).
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.
